Development of a robust and stable mass based spectrometry method for analysis of Alzheimer’s disease biomarkers in human cerebrospinal fluid
Leslie S, Wilson R, Trombetta B, Kivisäkk P, Arnold S, Nairn A, Carlyle B. Development of a robust and stable mass based spectrometry method for analysis of Alzheimer’s disease biomarkers in human cerebrospinal fluid. Alzheimer's & Dementia 2020, 16 DOI: 10.1002/alz.042035.Peer-Reviewed Original ResearchPutative proteinData-independent acquisition mass spectrometryAcquisition mass spectrometryData-independent acquisition (DIA) techniqueTechnical reproducibilityThousands of peptidesLow abundanceProtein analysisDisease biomarkersMass spectrometryProtein levelsProteinBiological conditionsProtein monitoring